• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
.[J].Journal Of Pharmaceutical Research,2024,43(8):798-805[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3146times   Download 2963次 QR Code for this article
Scan with your phone!
m6A相关蛋白抑制剂的研究进展
刘千姿1,全怡舟2,范一苇3,朱宇3,谢小娜4,赵承光3,赵海洋1
Font:Larger+|Default|Smaller-
(1.温州大学生命与环境科学学院,浙江省生物医药协同创新中心,浙江 温州 325035;2.北京中医药大学中药学院,北京 100102;3.温州医科大学药学院,浙江 温州 325035;4.温州医科大学附属第一医院,浙江 温州 325035)
摘要:
关键词:  N6-甲基腺苷  甲基转移酶  去甲基化酶  肿瘤  抑制剂
DOI:10.13506/j.cnki.jpr.2024.08.013
基金项目:国家自然科学基金(No.82173856、82303105);浙江省自然科学基金(No.LY21H300005、LTGY23H160019)温州市科技局(No.ZY2020025)
Publication Date:August 30, 2024
()
Abstract:
Key words:  
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.